Immunotherapy and the Risk of Myocarditis – Cancer Therapy Advisor
Cancer Therapy Advisor |
Immunotherapy and the Risk of Myocarditis
Cancer Therapy Advisor The risk should not discourage patients with cancer from taking these potentially life-extending therapies. Combinations of immune checkpoint inhibitors have the potential to cause fatal cases of fulminant myocarditis in patients with cancer, according … |
